No Image
Polyclonal Antibodies
Anti-COG2 Rabbit Polyclonal Antibody for WB, IHC-P, ELISA - Q14746
Item Number : CM0027737
Price varies based on specs and customizations
- Application
- WB, IHC-P, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 83kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | COG2 Rabbit pAb |
| Remarks/Alias | LDLC; CDG2Q; COG2 |
| Species | Human |
| GeneID (Human) | 22796 |
| GeneID | 22796 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-280 of human COG2 (NP_031383.1) |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, IHC-P, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | Q14746 |
| Protein Weight | 83kDa |
| Shipping | Ice bag |
Biological Background: COG2 Function and Localization
- COG2, also known as LDLC or CDG2Q, is a subunit of the conserved oligomeric Golgi (COG) complex, a multi-protein tethering complex essential for intra-Golgi vesicular trafficking and maintaining Golgi structure.
- The COG complex is composed of eight subunits (COG1-8) organized into two lobes; COG2 belongs to the lobe A subcomplex along with COG1, COG3, and COG4, and is critical for tethering vesicles to Golgi membranes.
- COG2 is required for normal Golgi morphology and function, ensuring proper retrograde and anterograde transport of glycosylation enzymes and thereby impacting protein glycosylation.
- Mutations in COG2 are associated with congenital disorders of glycosylation (CDG), specifically CDG type IIq (CDG2Q), characterized by defective glycosylation and severe multisystem disorders.
- The protein localizes to the Golgi apparatus membrane and is involved in membrane protein transport pathways.
- Alternative splicing of the COG2 gene generates multiple transcript variants, potentially modulating complex assembly or tissue-specific functions.
- COG2 was originally identified as a low density lipoprotein receptor defect C-complementing protein (LDLC), underscoring its role in LDL receptor stability and function.
Experimental Guidance and Technical Tips
- The immunogen covers the N-terminal region (amino acids 1-280) of human COG2, which is conserved across human, mouse, and rat, supporting expected cross-reactivity. Validation in the relevant sample system is recommended.
- For Western blotting, the predicted molecular weight of COG2 is approximately 83 kDa. Use appropriate loading controls and optimize blocking and detection conditions.
- In immunohistochemistry (IHC-P), antigen retrieval may be necessary due to formaldehyde fixation; consider optimizing the dilution and incubation parameters for your specific tissue type.
- When performing ELISA, the polyclonal nature of the antibody provides robust detection sensitivity; pair with suitable secondary reagents and validate linearity.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio is your trusted one-stop partner for IVD raw-material sourcing, offering validated antibodies and ancillary reagents to accelerate diagnostic development. This anti-COG2 polyclonal antibody supports research into Golgi morphology, protein trafficking, and congenital disorders of glycosylation. Beyond this product, CamelBio provides comprehensive offerings including antibody pairs, optimized monoclonal/polyclonal antibodies, and bulk reagents, all backed by expert technical support to streamline your path from concept to clinic.
Product Datasheet
Anti-COG2 Rabbit Polyclonal Antibody for WB, IHC-P, ELISA - Q14746
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!